Mirjam A. Apperloo
Leeuwarden, FR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Menopause-related quality of life 5 years after salpingectomy with delayed oophorectomy vs salpingo-oophorectomy.
Journal: Journal of the National Cancer Institute
Published: December 15, 2025
Pregnancy outcomes after laparotomic or laparoscopic myomectomy: A multicenter retrospective cohort study.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: September 11, 2025
Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study.
Journal: Maturitas
Published: August 12, 2025
Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference Trial.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: July 01, 2024
Effect of reduced follow-up care on patient satisfaction with care among patients with endometrial cancer: The ENSURE randomized controlled trial.
Journal: Gynecologic oncology
Published: January 25, 2024
Very early medical abortion, a termination of pregnancy before ultrasound evidence: something to aim for in the Netherlands?
Journal: Nederlands tijdschrift voor geneeskunde
Published: December 02, 2021
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 18, 2021
Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: Long-term outcomes of a randomised trial.
Journal: Gynecologic oncology
Published: August 03, 2021
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.
Journal: JAMA oncology
Published: June 03, 2021
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
Journal: Gynecologic oncology
Published: May 10, 2021
Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.
Journal: Clinical nuclear medicine
Published: July 13, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026